56 related articles for article (PubMed ID: 24688520)
1. Wild and partially synanthropic bird yeast diversity, in vitro virulence, and antifungal susceptibility of Candida parapsilosis and Candida tropicalis strains isolated from feces.
Glushakova A; Kachalkin A
Int Microbiol; 2024 Jun; 27(3):883-897. PubMed ID: 37874524
[TBL] [Abstract][Full Text] [Related]
2. Identification and evaluation of thermotolerance of yeasts from milk in natura exposed to high temperature and slow and fast pasteurization.
da Silva Campos J; Júnior ACV; Boniek D; da Silva DL; de Paula Lana UG; Fernandes JV; de Resende Stoianoff MA; Andrade VS
Braz J Microbiol; 2023 Jun; 54(2):1075-1082. PubMed ID: 37081263
[TBL] [Abstract][Full Text] [Related]
3. Distribution and impact of yeast thermal tolerance permissive for mammalian infection.
Robert V; Cardinali G; Casadevall A
BMC Biol; 2015 Feb; 13():18. PubMed ID: 25762372
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry-based VITEK MS system for the identification of Acinetobacter species from blood cultures: comparison with VITEK 2 and MicroScan systems.
Lee SY; Shin JH; Kim SH; Shin MG; Suh SP; Ryang DW
Ann Lab Med; 2015 Jan; 35(1):62-8. PubMed ID: 25553282
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of Vitek 2 for the identification of Candida yeasts].
Ochiuzzi ME; Cataldi S; Guelfand L; Maldonado I; Arechavala A;
Rev Argent Microbiol; 2014; 46(2):107-10. PubMed ID: 25011593
[TBL] [Abstract][Full Text] [Related]
6. Multicenter evaluation of the new Vitek 2 yeast susceptibility test using new CLSI clinical breakpoints for fluconazole.
Pfaller MA; Diekema DJ; Procop GW; Wiederhold NP
J Clin Microbiol; 2014 Jun; 52(6):2126-30. PubMed ID: 24719450
[TBL] [Abstract][Full Text] [Related]
7. Advanced approach for antifungal susceptibility and characterization of resistance properties in clinical and environmental isolates of
Lahiri S; Chandrashekar N
Infect Med (Beijing); 2022 Sep; 1(3):147-153. PubMed ID: 38077629
[TBL] [Abstract][Full Text] [Related]
8. A study of the association between virulence factors and antifungal susceptibility profile of
Siddiqui R; Mendiratta DK; Siddiqui AF; Rukadikar A
J Family Med Prim Care; 2023 Jan; 12(1):152-159. PubMed ID: 37025213
[TBL] [Abstract][Full Text] [Related]
9. High Prevalence of
Huilca-Ibarra MP; Vasco-Julio D; Ledesma Y; Guerrero-Freire S; Zurita J; Castillejo P; Barceló Blasco F; Yanez L; Changoluisa D; Echeverría G; Bastidas-Caldes C; Waard JH
Vet Sci; 2022 Nov; 9(12):. PubMed ID: 36548820
[TBL] [Abstract][Full Text] [Related]
10. Metagenomic Assessment of the Pathogenic Risk of Microorganisms in Sputum of Postoperative Patients With Pulmonary Infection.
Chen J; Sun L; Liu X; Yu Q; Qin K; Cao X; Gu J
Front Cell Infect Microbiol; 2022; 12():855839. PubMed ID: 35310849
[TBL] [Abstract][Full Text] [Related]
11. Virulence Factors and Antifungal Susceptibility Profile of
El-Kholy MA; Helaly GF; El Ghazzawi EF; El-Sawaf G; Shawky SM
J Fungi (Basel); 2021 Apr; 7(5):. PubMed ID: 33947158
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and Antifungal Susceptibility Profile of Clinically Relevant
Al Halteet S; Abdel-Hadi A; Hassan M; Awad M
Biomed Res Int; 2020; 2020():7042490. PubMed ID: 33294451
[TBL] [Abstract][Full Text] [Related]
13. [Identification and susceptibility profile of
Aguilar G; Araujo P; Lird G; Insaurralde S; Kawabata A; Ayala E; Irala J; Argüello R
Rev Panam Salud Publica; 2020; 44():e34. PubMed ID: 32973893
[TBL] [Abstract][Full Text] [Related]
14.
Alkharashi N; Aljohani S; Layqah L; Masuadi E; Baharoon W; Al-Jahdali H; Baharoon S
Can J Infect Dis Med Microbiol; 2019; 2019():2015692. PubMed ID: 31929847
[TBL] [Abstract][Full Text] [Related]
15. Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern.
Bitew A; Abebaw Y
BMC Womens Health; 2018 Jun; 18(1):94. PubMed ID: 29902998
[TBL] [Abstract][Full Text] [Related]
16. Identification and Antifungal Susceptibility Testing of
Kaur R; Dhakad MS; Goyal R; Haque A; Mukhopadhyay G
J Glob Infect Dis; 2016; 8(4):139-146. PubMed ID: 27942193
[TBL] [Abstract][Full Text] [Related]
17. SUSCEPTIBILITY TEST FOR FUNGI: CLINICAL AND LABORATORIAL CORRELATIONS IN MEDICAL MYCOLOGY.
Alastruey-Izquierdo A; Melhem MS; Bonfietti LX; Rodriguez-Tudela JL
Rev Inst Med Trop Sao Paulo; 2015 Sep; 57 Suppl 19(Suppl 19):57-64. PubMed ID: 26465371
[TBL] [Abstract][Full Text] [Related]
18. Are the Conventional Commercial Yeast Identification Methods Still Helpful in the Era of New Clinical Microbiology Diagnostics? A Meta-Analysis of Their Accuracy.
Posteraro B; Efremov L; Leoncini E; Amore R; Posteraro P; Ricciardi W; Sanguinetti M
J Clin Microbiol; 2015 Aug; 53(8):2439-50. PubMed ID: 25994160
[TBL] [Abstract][Full Text] [Related]
19. Use of the VITEK 2 system to identify and test the antifungal susceptibility of clinically relevant yeast species.
Melhem MS; Bertoletti A; Lucca HR; Silva RB; Meneghin FA; Szeszs MW
Braz J Microbiol; 2013 Dec; 44(4):1257-66. PubMed ID: 24688520
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
